Abiopharma

🔍 PUCKETT DAN (Director)

Company: PROCEPT BioRobotics Corp (PRCT)

Report Date: 2026-03-05

Detailed Transactions and Holdings:

• Acquired 5,476 shares of Common Stock (Direct)
  Date: 2026-03-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,476.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 8,897 shares of Stock Option (Right to Buy) at $25.35 per share (Derivative)
  Date: 2026-03-05 | Code: A | Expires: 2036-03-04 | equity_swap_involved: 0 | shares_owned_after: 8,897.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-third of the RSUs shall vest on March 5, 2027, with one-third of the remaining RSUs vesting annually on each of the second and third anniversary thereof, subject to the Reporting Person continuing as a service provider through such date.
• F2: This Stock Option was granted on March 5, 2026, and one-third of the shares subject to the Stock Option shall vest on March 5, 2027, with one-third of the remaining shares subject to the Stock Option vesting annually on each of the second and third anniversary thereof, subject to the Reporting Person continuing as a service provider through such date.